Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Oximetry Monitoring Recommended During PAP Initiation for Sleep Apnea in Patients With Obesity or Nocturnal Hypoxemia.

Koivumäki V, Maasilta P, Bachour A.

J Clin Sleep Med. 2018 Nov 15;14(11):1859-1863. doi: 10.5664/jcsm.7480.

2.

Bubbling test to recognize retrograde air escape via the nasolacrimal system during positive airway pressure therapy.

Bachour A, Maasilta P, Wares J, Uusitalo M.

Sleep Med. 2017 Jan;29:35-36. doi: 10.1016/j.sleep.2016.08.026. Epub 2016 Nov 5. No abstract available.

PMID:
28153213
3.

The effect of CPAP treatment for obstructive sleep apnea on asthma control-study limitations-author's response.

Kauppi P, Bachour P, Maasilta P, Bachour A.

Sleep Breath. 2016 Dec;20(4):1271-1272. doi: 10.1007/s11325-016-1386-0. Epub 2016 Jul 20. No abstract available.

PMID:
27438725
4.

Need for medication and stuffy nose predict the severity of allergic rhinitis.

Salo T, Peura S, Salimäki J, Maasilta P, Haahtela T, Kauppi P.

Asia Pac Allergy. 2016 Apr;6(2):133-5. doi: 10.5415/apallergy.2016.6.2.133. Epub 2016 Apr 28. No abstract available.

5.

Long-term CPAP treatment improves asthma control in patients with asthma and obstructive sleep apnoea.

Kauppi P, Bachour P, Maasilta P, Bachour A.

Sleep Breath. 2016 Dec;20(4):1217-1224. doi: 10.1007/s11325-016-1340-1. Epub 2016 Apr 7.

PMID:
27055688
6.

Oral appliance in sleep apnea treatment: respiratory and clinical effects and long-term adherence.

Bachour P, Bachour A, Kauppi P, Maasilta P, Mäkitie A, Palotie T.

Sleep Breath. 2016 May;20(2):805-12. doi: 10.1007/s11325-015-1301-0. Epub 2016 Jan 11.

PMID:
26754931
7.

Persistence of Upper-Airway Symptoms During CPAP Compromises Adherence at 1 Year.

Kreivi HR, Maasilta P, Bachour A.

Respir Care. 2016 May;61(5):652-7. doi: 10.4187/respcare.04113. Epub 2016 Jan 5.

8.

Rates of initial acceptance of PAP masks and outcomes of mask switching.

Bachour A, Vitikainen P, Maasilta P.

Sleep Breath. 2016 May;20(2):733-8. doi: 10.1007/s11325-015-1292-x. Epub 2015 Dec 10.

PMID:
26661645
9.
10.

Electro-oculography-based detection of sleep-wake in sleep apnea patients.

Virkkala J, Toppila J, Maasilta P, Bachour A.

Sleep Breath. 2015 Sep;19(3):785-9. doi: 10.1007/s11325-014-1060-3. Epub 2014 Oct 1.

PMID:
25269754
11.

Willingness score obtained after a short CPAP trial predicts CPAP use at 1 year.

Kreivi HR, Maasilta P, Bachour A.

Sleep Breath. 2014 Mar;18(1):207-13. doi: 10.1007/s11325-013-0872-x. Epub 2013 Jun 28.

PMID:
23812639
12.

CPAP interface: satisfaction and side effects.

Bachour A, Vitikainen P, Virkkula P, Maasilta P.

Sleep Breath. 2013 May;17(2):667-72. doi: 10.1007/s11325-012-0740-0. Epub 2012 Jul 5.

PMID:
22763499
13.

Screening of snoring with an MP3 recorder.

Kreivi HR, Salmi T, Maasilta P, Bachour A.

Sleep Breath. 2013 Mar;17(1):77-84. doi: 10.1007/s11325-012-0652-z. Epub 2012 Jan 27.

PMID:
22278148
14.

Ingraft chimerism in lung transplantation--a study in a porcine model of obliterative bronchiolitis.

Päiväniemi OE, Musilova P, Raivio PM, Maasilta PK, Alho HS, Rubes J, Aittomäki K, Salminen US.

Respir Res. 2011 Apr 26;12:56. doi: 10.1186/1465-9921-12-56.

15.

Impact of early angiographic evaluation on the frequency of emergency reoperations after coronary bypass surgery.

Karhunen J, Raivio P, Maasilta P, Sihvo E, Suojaranta-Ylinen R, Vento A, Salminen US.

Scand J Surg. 2010;99(3):173-9.

PMID:
21044936
16.

Outcome of aortic valve replacement with bioprostheses in the elderly.

Suojaranta-Ylinen RT, Soisalon-Soininen S, Kaartinen M, Maasilta PK, Vainikka TL, Vento AE, Salminen US.

J Heart Valve Dis. 2009 Sep;18(5):514-23.

PMID:
20099692
17.

Modelling individual space-time exposure opportunities: a novel approach to unravelling the genetic or environment disease causation debate.

Sabel CE, Boyle P, Raab G, Löytönen M, Maasilta P.

Spat Spatiotemporal Epidemiol. 2009 Oct-Dec;1(1):85-94. doi: 10.1016/j.sste.2009.07.002. Epub 2009 Aug 11.

PMID:
22749415
18.

Local C-reactive protein expression in obliterative lesions and the bronchial wall in posttransplant obliterative bronchiolitis.

Päiväniemi OE, Maasilta PK, Vainikka TL, Alho HS, Karhunen PJ, Salminen US.

Mediators Inflamm. 2009;2009:510254. doi: 10.1155/2009/510254. Epub 2009 May 26.

19.

Effects and side-effects of surgery for snoring and obstructive sleep apnea--a systematic review.

Franklin KA, Anttila H, Axelsson S, Gislason T, Maasilta P, Myhre KI, Rehnqvist N.

Sleep. 2009 Jan;32(1):27-36. Review.

20.

Epithelial tenascin predicts obliterative airway disease.

Päiväniemi OE, Maasilta PK, Alho HS, Vainikka TL, Salminen US.

J Heart Lung Transplant. 2008 Apr;27(4):400-7. doi: 10.1016/j.healun.2008.01.009.

PMID:
18374876
21.

Increased plasma levels of inflammatory markers and upper airway resistance during sleep in pre-eclampsia.

Bachour A, Teramo K, Hiilesmaa V, Maasilta P.

Sleep Med. 2008 Aug;9(6):667-74. Epub 2007 Oct 24.

PMID:
17921067
22.
23.

AutoCPAP initiation at home: optimal trial duration and cost-effectiveness.

Bachour A, Virkkala JT, Maasilta PK.

Sleep Med. 2007 Nov;8(7-8):704-10. Epub 2007 May 24.

PMID:
17531533
24.

Smoking and improvement after nasal surgery in snoring men.

Virkkula P, Hytönen M, Bachour A, Malmberg H, Hurmerinta K, Salmi T, Maasilta P.

Am J Rhinol. 2007 Mar-Apr;21(2):169-73.

PMID:
17424873
25.

Tenascin is expressed in post-transplant obliterative bronchiolitis.

Päiväniemi O, Alho H, Maasilta P, Vainikka T, Salminen US.

Transplant Proc. 2006 Oct;38(8):2694-6.

PMID:
17098042
26.

COX-2 is widely expressed in metaplastic epithelium in pulmonary fibrous disorders.

Lappi-Blanco E, Kaarteenaho-Wiik R, Maasilta PK, Anttila S, Pääkkö P, Wolff HJ.

Am J Clin Pathol. 2006 Nov;126(5):717-24.

PMID:
17050069
27.

Snoring is not relieved by nasal surgery despite improvement in nasal resistance.

Virkkula P, Bachour A, Hytönen M, Salmi T, Malmberg H, Hurmerinta K, Maasilta P.

Chest. 2006 Jan;129(1):81-7.

PMID:
16424416
28.

Patient- and bed partner-reported symptoms, smoking, and nasal resistance in sleep-disordered breathing.

Virkkula P, Bachour A, Hytönen M, Malmberg H, Salmi T, Maasilta P.

Chest. 2005 Oct;128(4):2176-82.

PMID:
16236871
29.

Immune cells in a heterotopic lamb-to-pig bronchial xenograft model.

Maasilta PK, Vainikka TL, Alho HS, Salminen US.

Transpl Int. 2005 Sep;18(9):1100-8.

30.

Matrix metalloproteinase induction in post-transplant obliterative bronchiolitis.

Eerola LM, Alho HS, Maasilta PK, Inkinen KA, Harjula AL, Litmanen SH, Salminen US.

J Heart Lung Transplant. 2005 Apr;24(4):426-32.

PMID:
15797744
31.

Platelet deposition on stainless steel, spiral, and braided polylactide stents. A comparative study.

Hietala EM, Maasilta P, Juuti H, Nuutinen JP, Harjula AL, Salminen US, Lassila R.

Thromb Haemost. 2004 Dec;92(6):1394-401.

PMID:
15583749
32.
33.

Cyclooxygenase-2 expression in experimental post-transplant obliterative bronchiolitis.

Päiväniemi OE, Maasilta PK, Alho HS, Wolff CH, Salminen US.

J Pathol. 2004 Nov;204(3):340-8.

PMID:
15476277
34.

Mouth closing device (chinstrap) reduces mouth leak during nasal CPAP.

Bachour A, Hurmerinta K, Maasilta P.

Sleep Med. 2004 May;5(3):261-7.

PMID:
15165532
35.

Platelet responses and coagulation activation on polylactide and heparin-polycaprolactone-L-lactide-coated polylactide stent struts.

Hietala EM, Maasilta P, Välimaa T, Harjula AL, Törmälä P, Salminen US, Lassila R.

J Biomed Mater Res A. 2003 Dec 1;67(3):785-91.

PMID:
14613226
36.

Epithelial apoptosis in experimental obliterative airway disease after lung transplantation.

Alho HS, Salminen US, Maasilta PK, Pääkkö P, Harjula AL.

J Heart Lung Transplant. 2003 Sep;22(9):1014-22.

PMID:
12957611
37.

Tumor necrosis factor-alpha in a porcine bronchial model of obliterative bronchiolitis.

Alho HS, Maasilta PK, Harjula AL, Hämmäinen P, Salminen J, Salminen US.

Transplantation. 2003 Aug 15;76(3):516-23.

PMID:
12923437
38.

Nasal obstruction and sleep-disordered breathing: the effect of supine body position on nasal measurements in snorers.

Virkkula P, Maasilta P, Hytönen M, Salmi T, Malmberg H.

Acta Otolaryngol. 2003 Jun;123(5):648-54.

PMID:
12875589
39.

Postural cephalometric analysis and nasal resistance in sleep-disordered breathing.

Virkkula P, Hurmerinta K, Löytönen M, Salmi T, Malmberg H, Maasilta P.

Laryngoscope. 2003 Jul;113(7):1166-74.

PMID:
12838015
40.

Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death.

Sabel CE, Boyle PJ, Löytönen M, Gatrell AC, Jokelainen M, Flowerdew R, Maasilta P.

Am J Epidemiol. 2003 May 15;157(10):898-905.

PMID:
12746242
41.

Magnetic resonance evaluation of luminal patency after polylactide stent implantation: an experimental study in a rabbit aorta model.

Hietala EM, Maasilta P, Ståhls A, Salminen US, Harjula AL, Välimaa T, Kivisaari L.

Eur Radiol. 2003 May;13(5):1025-32. Epub 2002 Jul 24.

PMID:
12695824
42.

Is there a cost-effective way to diagnose mild sleep-disordered breathing?

Bachour A, Herrala J, Maasilta P.

Respir Med. 2002 Aug;96(8):586-93.

43.

Esophageal pressure monitoring in detection of sleep-disordered breathing.

Virkkula P, Silvola J, Maasilta P, Malmberg H, Salmi T.

Laryngoscope. 2002 Jul;112(7 Pt 1):1264-70.

PMID:
12169911
44.

Nitric oxide in the development of obliterative bronchiolitis in a heterotopic pig model.

Salminen US, Maasilta PK, Harjula AL, Romanska HM, Bishop AE, Polak JM.

Transplantation. 2002 Jun 15;73(11):1724-9.

PMID:
12084993
45.

Pulmonary toxicity after radiotherapy in primary breast cancer patients: results from a randomized chemotherapy study.

Hernberg M, Virkkunen P, Maasilta P, Keyriläinen J, Blomqvist C, Bergh J, Wiklund T.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):128-36.

PMID:
11777630
46.

Sleep-related disordered breathing during pregnancy in obese women.

Maasilta P, Bachour A, Teramo K, Polo O, Laitinen LA.

Chest. 2001 Nov;120(5):1448-54.

PMID:
11713118
47.

Collagens I and III in a porcine bronchial model of obliterative bronchiolitis.

Alho HS, Inkinen KA, Salminen US, Maasilta PK, Taskinen EI, Glumoff V, Vuorio EI, Ikonen TS, Harjula AL.

Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1519-25.

PMID:
11704606
48.

Mortality from amyotrophic lateral sclerosis in Finland, 1986-1995.

Maasilta P, Jokelainen M, Löytönen M, Sabel CE, Gatrell AC.

Acta Neurol Scand. 2001 Oct;104(4):232-5.

PMID:
11589652
49.

Immune cells and immunosuppression in a porcine bronchial model of obliterative bronchiolitis.

Maasilta PK, Salminen US, Lautenschlager IT, Taskinen EI, Harjula AL.

Transplantation. 2001 Sep 27;72(6):998-1005.

PMID:
11579291
50.

Biodegradation of the copolymeric polylactide stent. Long-term follow-up in a rabbit aorta model.

Hietala EM, Salminen US, Ståhls A, Välimaa T, Maasilta P, Törmälä P, Nieminen MS, Harjula AL.

J Vasc Res. 2001 Jul-Aug;38(4):361-9.

PMID:
11455207

Supplemental Content

Loading ...
Support Center